Helping People Live Their Healthiest Lives
Telligen is a trusted partner for U.S. government health agencies, state Medicaid agencies, self-funded employer and Taft-Hartley health plans, and managed care organizations, improving health outcomes for millions of people nationwide through proven health management solutions and healthcare expertise.
TRUSTED TO DELIVER RESULTS
Federal
Telligen provides quality improvement, data analytics, quality measures, program management, and HIT solutions and services to federal health agencies and national programs.
state
Telligen helps state governments and programs ensure appropriate utilization management of healthcare services, improve clinical outcomes for patients and manage healthcare costs.
employers & self-funded plans
Telligen partners with self-funded employers, unions, Taft-Hartley health plans, and their brokers and consultants to improve the health and well-being of the workforce.
health plans
Telligen assists health plans specializing in Medicare Advantage, Medicaid managed care and marketplace services by providing solutions to help improve the health of individuals deemed most vulnerable.
Telligen is proud to announce it has been awarded the National Committee for Quality Assurance Population Health Program Accreditation in recognition of our robust infrastructure, procedures, and personnel, specifically in the realm of population health.
latest news
Telligen Wins Award for Innovative Blue Ribbon Prior Authorization Program
The following release was published on March 24, 2026 by MCG Health announcing Telligen as the recipient of the Richard L. Doyle Award for Innovation and Leadership in Healthcare. Telligen Honored with the Richard L. Doyle Award for Innovative ‘Blue-Ribbon’ Prior...
Latest Qualitrac Updates and Enhancements
Telligen is excited to announce its final 2025 update on enhancements made to our latest Qualitrac release (2025.04). Our clinical and technical...
Jane Brock, MD, MSPH, Honored with 2026 Jean Moody-Williams Patient Safety Award by CMS
[West Des Moines, IA] – [March 17, 2026] — Telligen is proud to announce that Jane Brock, MD, MSPH, has been named a recipient of the prestigious...
Telligen Recognized on the 2025 Best Evergreen Companies® List by Tugboat Institute®
[West Des Moines, IA] – [March 17, 2026] — Telligen is proud to announce that it has once again been named to the 2025 Best Evergreen Companies® by...
New Podcast Episode: Addressing Stigma and Enhancing Care for Substance Use
(Click the episode title to hear the full episode on Spotify) Sarah Andrews, MD, Medical Director at Telligen, joins us to talk about Substance Use Disorder and the stigma and barriers that impede effective treatment and recovery. Learn more about Substance Use...
Proactive Healthcare: Stopping Emergency Department Visits Before They Happen
Every year, unnecessary Emergency Department visits, or ED visits cost US healthcare payers $32 billion, with $8.3 billion of that attributed to...
Addressing Stigma and Enhancing Care for Substance Use
Healthcare Intelligence is a content series dedicated to exploring the latest trends, news and research across the entire spectrum of health and...
HippVinci Announces the Appointment of Terry Leahy, J.D., to its Board of Directors
HippVinci, the holding company for Telligen, a 100 percent employee-owned ESOP company, is pleased to announce the appointment of Terrence J. Leahy,...